2011
DOI: 10.1089/adt.2010.0326
|View full text |Cite
|
Sign up to set email alerts
|

A Screen to Identify Small Molecule Inhibitors of Protein–Protein Interactions in Mycobacteria

Abstract: Despite extensive efforts in tuberculosis (TB) drug research, very few novel inhibitors have been discovered. This issue emphasizes the need for innovative methods to discover new anti-TB drugs. In this study, we established a new high-throughput screen (HTS) platform technology that differs from traditional TB drug screens because it utilizes Mycobacterial-Protein Fragment Complementation (M-PFC) to identify small molecule inhibitors of protein-protein interactions in mycobacteria. Several examples of protein… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
16
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(16 citation statements)
references
References 84 publications
0
16
0
Order By: Relevance
“…Indeed, the bacterial or host-pathogen protein interactomes provide invaluable insights for the identification of novel antimicrobial drug targets, as successfully accomplished in cases of many human pathogens 810 . A wealth of data involving host- B .…”
Section: Introductionmentioning
confidence: 99%
“…Indeed, the bacterial or host-pathogen protein interactomes provide invaluable insights for the identification of novel antimicrobial drug targets, as successfully accomplished in cases of many human pathogens 810 . A wealth of data involving host- B .…”
Section: Introductionmentioning
confidence: 99%
“…The wide TRIM susceptibility window between the strains encoding dimerization-proficient and dimerizationimpaired EspR proteins together with the specific correlations between EspR homodimerization, TRIM concentration, and bacterial survival allow for a sensitive and quantitative assay that can be performed in a high-throughput manner (20,26). Screening and characterizing potential antivirulence compounds targeting EspR will be the focus of further research.…”
Section: Discussionmentioning
confidence: 99%
“…DosRST TCS comprises the DosR response regulator and the DosS and DosT histidine kinases that play an essential role in triggering and maintaining dormancy and 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 Several sets of small molecules have been assayed for their inhibition of DosR activity (63) (64). Several small molecules have been described as DosR inhibitors that bind DosR and inhibit its binding to its target DNA sequence (63).…”
Section: Targeting M Tuberculosis Persistence Through Inhibition Of mentioning
confidence: 99%